2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Molecular Testing, Omics Technologies, Bioinformatics, Blood Banking, Cell Expansion, Computational Biology, Emerging Technologies, Profiling, Treatment Considerations, Drug Development, Supportive Care, Biological Therapies, Transfusion, Non-Biological Therapies, Devices, Women’s Health, Adverse Events, Biological Processes, Apoptosis, Hematopoiesis, Immune Mechanism, Molecular Biology, Clinical Practice (Health Services and Quality), Clinical Guidelines, Diseases, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Study Population, Human, Adult, Animal Model
PAPER

2907 The stabilin-2 – von Willebrand factor (VWF) axis in vaso-occlusive pathophysiology and organ damage associated with sickle cell disease

Rima Chattopadhyay, Ph.D., Tomasz W Kaminski, PhD, MSc, PharmD2, Marta Wolosowicz, PhD, MBA3, Ayyanar Sivanantham, PhD4, Tirthadipa Pradhan-Sundd, PhD5
1 Versiti, Milwaukee, Wisconsin, United States
2 Versiti, Milwaukee, Wisconsin, United States
3 Versiti, Milwaukee, Wisconsin, United States
4 Versiti, Milwaukee, Wisconsin, United States
5 Versiti, Milwaukee, Wisconsin, United States

Background

Sickle cell disease (SCD) is a hereditary hemolytic disorder characterized by chronic intravascular hemolysis and the release of cell-free hemoglobin (Hb) into the circulation. Accumulation of Hb is associated with endothelial activation, vaso occlusion, and oxidative stress promoting sterile inflammation and organ damage in SCD. Liver is the major site for the clearance of cell-free hemoglobin (Hb). Recently, we and others have found that liver sinusoidal endothelial cells (LSECs) accumulate Hb in the liver. As a downstream effect of endothelial Hb accumulation, VWF expression was enhanced in the LSECs of SCD mice. Previous research has shown that VWF expression positively correlates with vaso occlusive pain crisis and venous thromboembolism (VTE) in SCD. However, the mechanism of VWF regulation in SCD, and how changes in VWF expression regulate SCD pathophysiology remain unknown. In this study, we examined VWF regulation in SCD mice at baseline and post-acute and chronic Hb challenge.

Aims

To identify the mechanism of cell free Hb mediated regulation of VWF in the LSECs of SCD mice.

Methods

Humanized Townes SCD mice were challenged with oxyhemoglobin (oxyHb), iron dextran, or LPS to mimic hemolytic challenges, followed by assessment of plasma and hepatic VWF levels. For in vitro studies, human umbilical vein endothelial cells (HUVECs) were treated with hemin chloride to mimic hemolytic conditions, followed by evaluation of VWF expression, intracellular trafficking, secretion and degradation.

Results

Cell-free Hb accumulation significantly increased VWF protein levels in both plasma and liver tissues of SCD mice at baseline and post oxyHb, iron dextran or LPS challenge. Western blot analysis revealed increased expression of both the extra-large multimers and cleaved form of VWF protein in SCD mice liver post Hb accumulation. In contrast, VWF mRNA expression, its intracellular processing, and endothelial secretion remained unchanged. Immunofluorescence analysis demonstrated that OxyHb challenge promotes VWF accumulation in hepatic Kupffer cells and LSECs, which colocalized with Hb. These data suggested that increased VWF accumulation results primarily from impaired clearance rather than enhanced synthesis or secretion in SCD. Using proximity ligation assay (PLA) assay, and coimmunoprecipitation, we demonstrated that VWF and Hb formed a complex in the SCD mice liver.  To further understand the effect of Hb in VWF clearance defect, we examined both canonical (ADAMTS13) and non-canonical (stabilin2) regulators of VWF clearance. Whereas ADAMTS13 expression was not significantly altered, we found a marked reduction in full-length stabilin 2 protein and an increase in the N-terminal form of stabilin 2 in the liver of SCD mice. Further analysis using HUVEC cells showed increased lysosomal accumulation of VWF post hemin treatment. Knocking down stabilin2 in SCD mice resulted in exacerbated vaso occlusion, hepatobiliary damage, and Hb-VWF accumulation. Research is currently underway to understand the clearance defect of VWF in SCD mice and the role of stbailin2 in this process.

Conclusion

Our findings demonstrate that hemolysis impairs hepatic VWF clearance through misexpression of Stabilin-2, resulting in pathological VWF accumulation during sickle cell disease. Our data also suggest that manipulation of stabilin 2 could be an effective strategy to modify Hb-VWF binding and clearance, hence preventing vaso occlusive pain crises and liver and other organ damage in SCD patients.

Rima Chattopadhyay, Ph.D.: No relevant conflicts of interest to declare.